Belize vs Ghana: Access to anti-retroviral drugs, female
Belize
51.0%
in 2024
Ghana
51.0%
in 2024
Belize rank
118th
Ghana rank
118th
Access to anti-retroviral drugs, female over time
- Belize
- Ghana
How they compare
Belize currently reports 51.0% against 51.0% in Ghana, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Ghana ahead.
Belize ranks 118th and Ghana ranks 118th of 141 countries.
Across the 3 decades both report, Belize averaged higher in 2 and Ghana in 1.
Head to head by decade
| Decade | Belize | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.1% | 2.5% | 6.6% | Belize |
| 2010s | 37.9% | 29.8% | 8.1% | Belize |
| 2020s | 47.8% | 48.0% | 0.2% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Belize or Ghana?
- Belize, at 51.0% against 51.0% in Ghana as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Belize and Ghana?
- 0.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Ghana?
- 25 years are reported by both, from 2000 to 2024.
- How do Belize and Ghana rank globally for access to anti-retroviral drugs, female?
- Belize ranks 118th and Ghana ranks 118th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.